Sanofi (SANp)

Euronext ParisHealthcare

€82.1
+€1.25 (+1.5%)
Market closed

April 17, 2026 at 17:30 UTC

Interactive Chart

SANp

08:28:18 UTC

About Sanofi

Name
Sanofi
CEO
Olivier Charmeil
Industry
Healthcare
Year Founded
1973
Employees
82,878

Sanofi is a healthcare company that discovers, manufactures, and supplies medicines and vaccines used in clinical practice. Clinical programs target evidence that can be translated into labeling, and medical information supports safe use after approval. Plants operate to validated procedures, and logistics are planned so pharmacies, hospitals, and clinics receive steady supply. Regional teams handle access and pharmacovigilance under local rules while global functions maintain shared standards. Reporting sits inside the healthcare sector with a focus on operating facts rather than narrative goals. The company describes its role as maintaining continuity for health systems while adding new options through measured change. The stance is process first, with patient safety and data integrity kept at the center of decisions.

Analyst Ratings

Consensus Recommendation
Analyst consensus: 3 Buy, 16 Hold, 4 Sell
Buy3
Hold16
Sell4

Fundamentals & Financials

Revenue (TTM)
€58.2B
Net Income (TTM)
€10.6B
EPS (TTM)
€6.35
ROA (TTM)
8.37%
Current Ratio
1.09
Dividend Yield
0%

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Income Statement

ItemQ4 2025
Revenue€23,737M
Cost of Sales€7,168M
Gross Profit€16,569M
Operating Income€7,407M
Net Income€2,001M
EPS€1.66

Technical Indicators

Sanofi's Technical Indicators Summary

Banco Santander’s listing presents a neutral technical picture with short-term averages marginally supportive while longer-term EMAs sit above the market, producing mixed signals. Momentum and RSI are modestly positive and MACD lacks strong conviction, while ADX indicates a weak trend. Volatility is moderate and OBV shows no clear accumulation pattern, and the classic pivot lies above the current price, offering a level of resistance. Overall indicators are balanced between shallow buying and longer-term overhead averages. Technical takeaway: Neutral technical posture with short-term support offset by longer-term moving-average resistance.

Buy
3 signals
Neutral
16 signals
Sell
4 signals
Overall: Neutral70% Neutral signals
IndicatorValue
RSI (14)
61.53
Stochastic %K (14, 3, 3)
CCI (20)
WPR (14)
Momentum (10)
-2.02
MFI
42.29
MACD Level (12, 26)
0.52
Bollinger Bands
ATR (14)
$1.69 (2.09%)
ADX (14)
14.68
OBV
6,066,981
Classic Pivot Point
$81.51
Fibonacci Pivot Point
$81.51
Simple Moving Averages
(5 indicators)
Exponential Moving Averages
$80.05 - $82.71(5 indicators)
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.

Today's Snapshot

The day wrapped with SANp preserving a mild 1.36% upside gap, closing near 81.95. The day closed with SANp still facing an upcoming earnings catalyst in 6 days on 23 April. SANp edges higher ahead of an upcoming earnings catalyst, maintaining a mild upside bias.

Price Change

from €82.1 close

-€0.04

Trading Volume

Below avg (2.4M)

907.9K

vs S&P 500 Today

Moderate Underperformance

-0.20%

52-Week Position

Lower range

30.2%

Updated: April 17, 2026 at 15:04 UTC

Quote Summary

OpenPrevious Close
€81.68€80.65
Day Range52 Week Range
€80.59 - €81.77€74.85 - €98.36
VolumeAvg. Volume
1.6M2.5M
Market CapP/E Ratio
€97.2B20.1